A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT00756444 · COMPLETED

Trial details

NCT number: NCT00756444
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2008-10-21
Primary completion: 2012-03-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.